Viking Therapeutics (VKTX) Earnings Date, Estimates & Call Transcripts $32.01 -0.06 (-0.19%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$32.20 +0.19 (+0.59%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Viking Therapeutics Earnings Summary Viking Therapeutics issued Q1 2025 earnings on April 23, 2025, reporting an EPS of -$0.41, which missed analysts' consensus estimates of -$0.31 by $0.10. Its revenue for the quarter was up .0% compared to the same quarter last year. With a trailing EPS of -$1.15, Viking Therapeutics' earnings are expected to decrease next year, from ($1.56) to ($2.07) per share. Upcoming Q2 Earnings DateJul. 23After Market ClosesEstimatedConsensus EPS (Apr. 23) -$0.31 Actual EPS (Apr. 23) -$0.41 Missed By -$0.10 Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)VKTX Upcoming EarningsViking Therapeutics' Q2 2025 earnings is scheduled for Wednesday, July 23, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get Viking Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Viking Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVKTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Viking Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$0.35-$0.26-$0.31Q2 20254-$0.45-$0.42-$0.44Q3 20254-$0.49-$0.45-$0.47Q4 20254-$0.52-$0.47-$0.49 FY 2025 16 -$1.81 -$1.60 -$1.70 Q1 20261-$0.54-$0.54-$0.54Q2 20261-$0.55-$0.55-$0.55Q3 20261-$0.56-$0.56-$0.56Q4 20261-$0.57-$0.57-$0.57 Viking Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/23/2025(Estimated)-------4/23/2025Q1 2025-$0.31-$0.41 -$0.10-$0.41--2/5/2025Q4 2024-$0.27-$0.32 -$0.05-$0.32--10/23/2024Q3 2024-$0.24-$0.22+$0.02-$0.22--7/24/2024Q2 2024-$0.26-$0.20+$0.06-$0.20--4/24/2024Q1 2024-$0.27-$0.26+$0.01-$0.26--2/7/2024Q4 2023-$0.25-$0.25--$0.25--10/25/2023Q3 2023-$0.22-$0.23 -$0.01-$0.23--7/26/2023Q2 2023-$0.21-$0.19+$0.02-$0.19-- Viking Therapeutics Earnings - Frequently Asked Questions When is Viking Therapeutics' earnings date? Viking Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 23rd, 2025 based off last year's report dates. Learn more on VKTX's earnings history. Did Viking Therapeutics beat their earnings estimates last quarter? In the previous quarter, Viking Therapeutics (NASDAQ:VKTX) missed the analysts' consensus estimate of ($0.31) by $0.10 with a reported earnings per share (EPS) of ($0.41). Learn more on analysts' earnings estimate vs. VKTX's actual earnings. How can I listen to Viking Therapeutics' earnings conference call? The conference call for Viking Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Viking Therapeutics' conference call transcript? The conference call transcript for Viking Therapeutics' latest earnings report can be read online. Read Transcript How much profit does Viking Therapeutics generate each year? Viking Therapeutics (NASDAQ:VKTX) has a recorded net income of -$109.96 million. VKTX has generated -$1.15 earnings per share over the last four quarters. What is Viking Therapeutics' EPS forecast for next year? Viking Therapeutics' earnings are expected to decrease from ($1.56) per share to ($2.07) per share in the next year. More Earnings Resources from MarketBeat Related Companies Madrigal Pharmaceuticals Earnings Results Eli Lilly and Company Earnings Results Intra-Cellular Therapies Earnings Results Genmab A/S Earnings Results Moderna Earnings Results Dr. Reddy's Laboratories Earnings Results Qiagen Earnings Results Viatris Earnings Results Ascendis Pharma A/S Earnings Results BridgeBio Pharma Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Netflix Q2 2025 Earnings: What Investors Need to KnowHow Goldman Sachs Earnings Help You Strategize Your PortfolioCitigroup Earnings Could Signal What’s Next for Markets3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings Report This page (NASDAQ:VKTX) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersCongress Is Talking Crypto. Here’s What It Means for You …Congress is deep into “Crypto Week” — with new bills that could finally bring clarity to digital assets. Cr...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VKTX Stock Alerts